EP4077321B1 - Process for preparing [3-chloro-2-[3-[2-[1-(2-chloroacetyl)-4-piperidyl]thiazol-4-yl]-4,5-dihydroisoxazol-5-yl]phenyl] methanesulfonate - Google Patents

Process for preparing [3-chloro-2-[3-[2-[1-(2-chloroacetyl)-4-piperidyl]thiazol-4-yl]-4,5-dihydroisoxazol-5-yl]phenyl] methanesulfonate Download PDF

Info

Publication number
EP4077321B1
EP4077321B1 EP20829885.1A EP20829885A EP4077321B1 EP 4077321 B1 EP4077321 B1 EP 4077321B1 EP 20829885 A EP20829885 A EP 20829885A EP 4077321 B1 EP4077321 B1 EP 4077321B1
Authority
EP
European Patent Office
Prior art keywords
formula
process according
compound
ethanol
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP20829885.1A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP4077321A1 (en
Inventor
Christoph SCHOTES
Marjorie Daniele Bernadet MASSEL
Matthias RIEDRICH
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of EP4077321A1 publication Critical patent/EP4077321A1/en
Application granted granted Critical
Publication of EP4077321B1 publication Critical patent/EP4077321B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Definitions

  • the present invention relates to a process for preparing [3-chloro-2-[3-[2-[1-(2-chloroacetyl)-4-piperidyl]thiazol-4-yl]-4,5-dihydroisoxazol-5-yl]phenyl] methanesulfonate.
  • [3-chloro-2-[3-[2-[1-(2-chloroacetyl)-4-piperidyl]thiazol-4-yl]-4,5-dihydroisoxazol-5-yl]phenyl] methanesulfonate is an intermediate of fluoxapiprolin, which is a fungicide for control of oomycetes known from WO 2012/025557 .
  • WO 2015/181097 discloses a process for preparing [3-chloro-2-[3-[2-[1-(2-chloroacetyl)-4-piperidyl]thiazol-4-yl]-4,5-dihydroisoxazol-5-yl]phenyl] methanesulfonate (compound of the formula (I)) via a chloroacetyl-substituted compound of the formula (II), which is reacted with piperidine-4-carbothioamide (III) in presence of hydrochloric acid and ethanol in a Hantzsch reaction to give a piperidinium salt of the formula (IV). The piperidinium salt of the formula (IV) is then converted to the compound of the formula (I) by reaction with chloroacetylchloride in presence of tributylamine and tetrahydrofuran as solvent (see Scheme 1).
  • step (a) of the process according to the invention the compound of formula (II) is reacted with the compound of formula (III) in presence of hydrogen chloride and an alcoholic solvent to give the hydrochloride salt of formula (IV).
  • Suitable alcoholic solvents are methanol, ethanol, n-propanol (propanol), iso-propanol, n-butanol (butanol), iso-butanol, sec-butanol and tert-butanol.
  • Preferred alcoholic solvents are isopropanol and ethanol. Most preferred is ethanol.
  • the hydrogen chloride is used in form of hydrochloric acid, more preferably hydrochloric acid having a HCl concentration of at least 20 wt.%, more preferably at least 30 wt.%, and in particular at least 35 wt.%.
  • step (a) is effected at temperatures of -20°C to + 120°C, preferably at temperatures of 20°C to +100°C, more preferably at 40°C to 80°C under standard pressure.
  • the compound of formula (III) is first converted to the corresponding hydrochloride in presence of the alcoholic solvent, before the compound of formula (II) is added.
  • the amount of hydrogen chloride used in step (a) is preferably within the range of from 1 mol to 3 mol, more preferably 1 mol to 2 mol, and most preferably 1 mol to 1.5 mol per 1 mol of the compound of formula (II).
  • the amount of the compound of formula (III) used in step (a) is preferably within the range of from 1 mol to 3 mol, more preferably 1 mol to 2 mol, and most preferably 1 mol to 1.5 mol per 1 mol of the compound of formula (II).
  • reaction time is not critical and may, according to the batch size and temperature, be selected within a range between a few minutes and several hours.
  • a suitable reaction time is for example between 2 h and 10 h.
  • step (b) of the process according to the invention the hydrochloride salt of the formula (IV) is reacted with chloroacetyl chloride in presence of a pyridine base, an aprotic solvent and an aromatic solvent having a boiling point of at least 160°C to give the compound of the formula (I).
  • the amount of chloroacetyl chloride used in step (b) is preferably within the range of from 1 mol to 5 mol, more preferably 1.5 mol to 4 mol, and most preferably 1.5 mol to 2.5 mol per 1 mol of the compound of formula (IV).
  • the reaction according to step (b) is preferably effected at temperatures of 0°C to +120°C, more preferably at temperatures of 20°C to 80°C, most preferably at 30°C to 60°C under standard pressure.
  • reaction time is not critical and may, according to the batch size and temperature, be selected within a range between a few minutes and several hours.
  • a suitable reaction time is for example between 1 h and 5h.
  • the pyridine base is an alkyl pyridine base.
  • Suitable alkyl pyridines which can be employed in the process according to the invention include the collidines, lutadines, picolines, the methylethyl pyridines, the diethyl pyridines, 2-isopropylpyridine, 2-propylpyridine, 2-methyl-3-propylpyridine, 2-ethyl-5-propylpyridine, 2-methyl-5-tert-butylpyridine, 2-ethyl-3-amylpyridine, 2-decylpyridine and 2-butyl-5-octylpyridine.
  • Preferred pyridine bases are selected from the picolines, lutidines, collidines, methylethyl pyridines and diethyl pyridines. Most preferred is 2-methyl-5-ethyl-pyridine.
  • the amount of pyridine base used is preferably within the range of from 1 mol to 20 mol, more preferably 2 mol to 10 mol, and most preferably 3 mol to 6 mol per 1 mol of the compound of formula (IV).
  • Suitable polar aprotic solvents are ethers such as diethyl ether, methyl tert-butyl ether, dibutyl ether, ethylenglycoldimethylether, diethylenglycoldimethylether, methyltetrahydrofuran, tetrahydrofuran and 1,4-dioxane, ketones such as acetone, methyl ethyl ketone, methyl isopropyl ketone and methyl isobutyl ketone, esters such as methyl acetate, ethyl acetate and butyl acetate, nitriles, for example acetonitrile, propionitrile and butyronitrile, amides, for example dimethylformamide, dimethylacetamide and N-methylpyrrolidone, dimethyl sulphoxide, tetramethylenesulphone, hexamethylphosphoramide and DMPU.
  • ethers such as die
  • acetonitrile Especially preferred is acetonitrile.
  • Suitable aromatic solvents having a boiling point of at least 160°C which can be employed in the process according to the invention include 1,3,5-trimethylbenzene (mesitylene), 1,2,3-trimethylbenzene, 1,2,4-trimethylbenzene, 1,2-dichlorobenzene, 1,3-dichlorobenzene, 1,4-dichlorobenzene, 1,2-dimethoxybenzene (veratrole), 1,3-dimethoxybenzene, 1,4-dimethoxybenzene, and mixtures thereof.
  • the aprotic solvent and the aromatic solvent having a boiling point of at least 160°C are preferably used in a ratio by weight of from 10:1 to 1:5, more preferably 5:1 to 1:2, and most preferably 3:1 to 1:1.
  • the aromatic solvent having a boiling point of at least 160°C is mesitylene.
  • Polar aprotic solvent and mesitylene are preferably used in a ratio by weight of from 10:1 to 1:5, more preferably 5:1 to 1:2, and most preferably 3:1 to 1:1.
  • the solvent is changed between steps (a) and (b) from alcoholic solvent to aprotic solvent by distillation.
  • at least 95 wt.%, more preferably at least 97% wt.%, in particular at least 99 wt.% of the alcoholic solvent are removed by said distillation.
  • hydrochloric acid is used in step (a), which is preferred according to the invention, part of the water from the hydrochloric acid, preferably at least 90 wt.%, more preferably at least 95 wt.%, most preferably at least 98% of the water from the hydrochloric acid, is also removed by said distillation.
  • At least part of the pyridine base and at least part of the aromatic solvent having a boiling point of at least 160°C, preferably mesitylene, are added prior to the distillation of the alcoholic solvent.
  • the alcoholic solvent used in step (a) is ethanol
  • the pyridine base is 2-methyl-5-ethyl-pyridine
  • the aprotic solvent used in step (b) is acetonitrile
  • the aromatic solvent having a boiling point of at least 160°C used in step (b) is mesitylene.
  • acetonitrile and mesitylene are preferably used in a ratio by weight of from 10:1 to 1:5, more preferably 5:1 to 1:2, and most preferably 3:1 to 1:1.
  • the reaction is stopped (quenched) by means of another solvent exchange.
  • the main portion of the solvent is preferably changed back from polar aprotic solvent to alcoholic solvent, wherein the alcoholic solvent used for the quench is preferably selected from ethanol, 1-butanol and 2-butanol, particularly preferred is ethanol.
  • Said solvent exchange may be conducted by (i) distilling off a main portion of the aprotic solvent, preferably acetonitrile, and (ii) addition of an alcoholic solvent, preferably selected from ethanol, 1-butanol and 2-butanol, more preferably ethanol.
  • the acetonitrile is removed by distillation and recycled, and the ethanol distillate obtained during the solvent exchange between steps (a) and (b) is re-used for the quench of the reaction giving the compound of formula (I).
  • the compound of formula (I) can then be filtered off, washed with water and dried.
  • the present invention also relates to a process for preparing fluoxapiprolin comprising the process for preparing the compound of the formula (I) according to the invention, and further comprising step (c) reacting the compound of the formula (I) obtained in step (b) with 3,5-bis(difluoromethyl)-1H-pyrazole.
  • acetonitrile 127 g of acetonitrile are distilled off at 250 mbar. 253 g of technical ethanol are added and the temperature is reduced to 0°C. After stirring overnight, 150 g of water are added and stirring is continued for 2 h. The suspension is filtered and washed with a combination of 78:22 w/w acetonitrile/ethanol (30 g) and 50 g of ethanol.
  • acetonitrile 131 g of acetonitrile are distilled off at 250 mbar. 121 g of technical ethanol are added and the temperature is reduced to 0 °C. After stirring overnight, 100 g of water are added and stirring is continued for 2 h. The suspension is filtered and washed with a combination of 78:22 w/w acetonitrile/ethanol (30 g) and 50 g of ethanol.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EP20829885.1A 2019-12-19 2020-12-16 Process for preparing [3-chloro-2-[3-[2-[1-(2-chloroacetyl)-4-piperidyl]thiazol-4-yl]-4,5-dihydroisoxazol-5-yl]phenyl] methanesulfonate Active EP4077321B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19217876 2019-12-19
PCT/EP2020/086428 WO2021122752A1 (en) 2019-12-19 2020-12-16 Process for preparing [3-chloro-2-[3-[2-[1-(2-chloroacetyl)-4-piperidyl]thiazol-4-yl]-4,5-dihydroisoxazol-5-yl]phenyl] methanesulfonate

Publications (2)

Publication Number Publication Date
EP4077321A1 EP4077321A1 (en) 2022-10-26
EP4077321B1 true EP4077321B1 (en) 2025-06-25

Family

ID=68965811

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20829885.1A Active EP4077321B1 (en) 2019-12-19 2020-12-16 Process for preparing [3-chloro-2-[3-[2-[1-(2-chloroacetyl)-4-piperidyl]thiazol-4-yl]-4,5-dihydroisoxazol-5-yl]phenyl] methanesulfonate

Country Status (12)

Country Link
US (1) US12503465B2 (da)
EP (1) EP4077321B1 (da)
JP (1) JP7781754B2 (da)
KR (1) KR20220118509A (da)
CN (1) CN114829360B (da)
DK (1) DK4077321T3 (da)
ES (1) ES3041339T3 (da)
FI (1) FI4077321T3 (da)
IL (1) IL293955A (da)
MX (1) MX2022007710A (da)
TW (1) TW202138369A (da)
WO (1) WO2021122752A1 (da)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008013622A2 (en) * 2006-07-27 2008-01-31 E. I. Du Pont De Nemours And Company Fungicidal azocyclic amides
US8759527B2 (en) 2010-08-25 2014-06-24 Bayer Cropscience Ag Heteroarylpiperidine and -piperazine derivatives as fungicides
JP6546936B2 (ja) 2014-05-28 2019-07-17 バイエル・クロップサイエンス・アクチェンゲゼルシャフト チアゾール誘導体を調製する方法

Also Published As

Publication number Publication date
FI4077321T3 (fi) 2025-09-30
TW202138369A (zh) 2021-10-16
KR20220118509A (ko) 2022-08-25
ES3041339T3 (en) 2025-11-11
WO2021122752A1 (en) 2021-06-24
US20230031599A1 (en) 2023-02-02
JP7781754B2 (ja) 2025-12-08
JP2023506300A (ja) 2023-02-15
CN114829360A (zh) 2022-07-29
EP4077321A1 (en) 2022-10-26
CN114829360B (zh) 2025-03-07
BR112022011843A2 (pt) 2022-08-30
IL293955A (en) 2022-08-01
US12503465B2 (en) 2025-12-23
MX2022007710A (es) 2022-07-19
DK4077321T3 (da) 2025-09-15

Similar Documents

Publication Publication Date Title
EP2285779B1 (de) Verfahren zur Herstellung von Arylcarboxamiden
EP2288597B1 (de) Verfahren zur herstellung von 1,3,4-substituierten pyrazolverbindungen
JP5656952B2 (ja) ピペラジン誘導体蓚酸塩結晶
EP4077321B1 (en) Process for preparing [3-chloro-2-[3-[2-[1-(2-chloroacetyl)-4-piperidyl]thiazol-4-yl]-4,5-dihydroisoxazol-5-yl]phenyl] methanesulfonate
KR102445983B1 (ko) 티아졸 유도체의 제조방법
KR101320746B1 (ko) 비닐렌 카르보네이트의 제조 방법
US9650347B2 (en) Process for producing pyridazinone compound and production intermediates thereof
BR112022011843B1 (pt) Processos para preparação de [3-cloro-2-[3-[2-[1-(2-cloroacetil)-4- piperidil]tiazol-4-il]-4,5-diidro-isoxazol-5-il]fenil] metanossulfonato e de fluoxapiprolina
CN100427454C (zh) 制备二氟乙酰乙酸烷基酯的方法
US6861522B2 (en) Process for the manufacture of thiazole derivatives with pesticidal activity
KR20070116851A (ko) 아미노메틸 티아졸 화합물의 제조 방법
JP4587202B2 (ja) フェニルオキサジアゾール類の製造法
EP2571854B1 (en) Method for manufacturing 1-alkyl-3-difluormethyl-5-hydroxypyrazoles
AU2002221751A1 (en) Process for the manufacture of thiazole derivatives with pesticidal activity
US6248888B1 (en) Process for the preparation of terazosin hydrochloride dihydrate
JP5064872B2 (ja) N−(2−アミノ−1,2−ジシアノビニル)イミデート類の製造方法
JP4067262B2 (ja) 二置換ニトログアニジン誘導体の製造方法
US7919618B2 (en) Synthesis of piperazines, piperidines and related compounds
US10093626B2 (en) Process for preparing piperidine-4-carbothioamide hydrochloride
CN107207435B (zh) 制备4-氰基哌啶盐酸盐的方法
JP4463461B2 (ja) 1,3−二置換2−ニトログアニジンの製造方法
JPH0586783B2 (da)
JP2004075616A (ja) 4−ハロゲノ−2−(4−フルオロフェニルアミノ)−5,6−ジメチルピリミジンの製造方法

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220719

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20231222

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20240923

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTC Intention to grant announced (deleted)
INTG Intention to grant announced

Effective date: 20250210

P01 Opt-out of the competence of the unified patent court (upc) registered

Free format text: CASE NUMBER: APP_12843/2025

Effective date: 20250314

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602020053435

Country of ref document: DE

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Effective date: 20250912

REG Reference to a national code

Ref country code: FI

Ref legal event code: FGE

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250926

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250925

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250625

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250625

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250925

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250625

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 3041339

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20251111

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20251027

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20251126

Year of fee payment: 6